SCHEMBL20154583

SCHEMBL20154583

CCC(C)N1CC2CC(C1)N2C(=O)c1ccc(OC(C)C)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.43
ALDH1A1 P00352 2/20 0.43
TP53 P04637 2/20 0.43
THRB P10828 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 2/20 0.43
HPGD P15428 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
PARP10 Q53GL7 1/20 0.42
RET P07949 1/20 0.41
LMNA P02545 1/20 0.40
TSHR P16473 1/20 0.40
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.38
MITF O75030 1/20 0.38
DRD3 P35462 2/20 0.38
DRD2 P14416 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22030863 0.92 ALDH1A1 (0.46) ALDH1A1HTTKMT2ARETTSHR
SCHEMBL20148732 0.87 KMT2A (0.47) MAPTALDH1A1TP53THRBHTT
SCHEMBL20153229 0.84 KMT2A (0.40) MAPTALDH1A1TP53THRBHTT
SCHEMBL22030865 0.83 KMT2A (0.49) MAPTALDH1A1TP53THRBHTT
SCHEMBL20152354 0.80 KMT2A (0.45) MAPTALDH1A1TP53THRBHTT
SCHEMBL20071116 0.79 ALDH1A1 (0.47) ALDH1A1HTTKMT2APARP10RET
SCHEMBL20071117 0.78 KMT2A (0.49) MAPTALDH1A1TP53THRBHTT
SCHEMBL22030589 0.73 GAA (0.41) KMT2ARETTSHRKDM4EMEN1
SCHEMBL22030862 0.73 ALDH1A1 (0.49) ALDH1A1HTTKMT2ANPC1RAB9A
SCHEMBL20160526 0.72 ELOVL6 (0.49) MAPTALDH1A1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10172851-B2 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors ARRAY BIOPHARMA INC. (US) 2019-01-08 US disclosed
US-20180133213-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10172851-B2 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors RET, ROR1, BRAF MAPT 1769/4885ALDH1A1 2868/4885TP53 1141/4885
US-20180133213-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, ROR1, BRAF MAPT 1769/4885ALDH1A1 2868/4885TP53 1141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.